JCI - Citations to Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.

Citations to this article

Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.

S D Rybalkin, … , E G Krebs, J A Beavo

S D Rybalkin, … , E G Krebs, J A Beavo

Published November 15, 1997
Citation Information: J Clin Invest. 1997;100(10):2611-2621. https://doi.org/10.1172/JCI119805.

View: Text | PDF

Research Article

Total citations by year

Year:	2024	2023	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1984	Total
Citations:	1	1	7	2	2	5	2	1	3	1	1	2	21	3	20	4	4	6	3	1	7	2	5	5	7	3	1	120

Citation information

Citations to this article (120)

Title and authors	Publication	Year
The perspective of cAMP/cGMP signaling and cyclic nucleotide phosphodiesterases in aortic aneurysm and dissection. Shu T, Zhou Y, Yan C	Vascular Pharmacology	2024
Phosphodiesterase in heart and vessels: from physiology to diseases Fu Q, Wang Y, Yan C, Xiang YK	Physiological reviews	2023
New Avenues for Phosphodiesterase Inhibitors in Asthma MG Matera, J Ora, F Cavalli, P Rogliani, M Cazzola	Journal of Experimental Pharmacology	2021
PDE-Mediated Cyclic Nucleotide Compartmentation in Vascular Smooth Muscle Cells: From Basic to a Clinical Perspective Lorigo M, Oliveira N, Cairrao E	Journal of Cardiovascular Development and Disease	2021
Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities A Samidurai, , A Das, AN Iness, NG Vigneshwar, PL Li, DK Singla, S Muniyan, SK Batra, RC Kukreja	Pharmacology & Therapeutics	2021
Phosphodiesterase 1C integrates store-operated calcium entry and cAMP signaling in leading-edge protrusions of migrating human arterial myocytes P Brzezinska, NJ Simpson, F Hubert, AN Jacobs, MB Umana, JL MacKeil, J Burke-Kleinman, DM Payne, AV Ferguson, DH Maurice	The Journal of biological chemistry	2021
Cyclic nucleotide phosphodiesterase 1C contributes to abdominal aortic aneurysm C Zhang, H Zhao, Y Cai, J Xiong, A Mohan, D Lou, H Shi, Y Zhang, X Long, J Wang, C Yan	Proceedings of the National Academy of Sciences	2021
Genome-Wide Association Study Based on Random Regression Model Reveals Candidate Genes Associated with Longitudinal Data in Chinese Simmental Beef Cattle L Du, X Duan, B An, T Chang, M Liang, L Xu, L Zhang, J Li, G E, H Gao	Animals	2021
Insulin Resistance is Associated with Subclinical Vascular Injury in Patients with a Kidney Disease. Adeva-Andany MM, Fernández-Fernández C, Adeva-Contreras L, Carneiro-Freire N, Domínguez-Montero A, Mouriño-Bayolo D	Current cardiology reviews	2021
Updates of Recent Vinpocetine Research in Treating Cardiovascular Diseases Chongyang Zhang, Chen Yan	Journal of cellular immunology	2020
Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway C Yang, X Wu, Y Shen, C Liu, X Kong, P Li	European Journal of Pharmacology	2020
The importance of the nitric oxide‐cGMP pathway in age‐related cardiovascular disease: Focus on phosphodiesterase‐1 and soluble guanylate cyclase K Golshiri, EA Ataabadi, EC Fernandez, AH Danser, AJ Roks	Basic & Clinical Pharmacology & Toxicology	2019
An EPAC1/PDE1C-Signaling Axis Regulates Formation of Leading-Edge Protrusion in Polarized Human Arterial Vascular Smooth Muscle Cells P Brzezinska, DH Maurice	Cells	2019
Mouse Cardiac Pde1C Is a Direct Transcriptional Target of Pparα V Shete, N Liu, Y Jia, N Viswakarma, J Reddy, B Thimmapaya	International journal of molecular sciences	2018
Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways D Wang, P Uhrin, A Mocan, B Waltenberger, JM Breuss, D Tewari, J Mihaly-Bison, Ł Huminiecki, RR Starzyński, NT Tzvetkov, J Horbańczuk, AG Atanasov	Biotechnology Advances	2018
Novel short isoforms of adenylyl cyclase as negative regulators of cAMP production B Vallin, Y Legueux-Cajgfinger, N Clément, M Glorian, L Duca, P Vincent, I Limon, R Blaise	Biochimica et Biophysica Acta (BBA) - Molecular Cell Research	2018
Histone demethylase JMJD6 regulates cellular migration and proliferation in adipose-derived mesenchymal stem cells C Shen, Q Quan, C Yang, Y Wen, H Li	Stem Cell Research & Therapy	2018
Roles of PDE1 in Pathological Cardiac Remodeling and Dysfunction S Chen, W Knight, C Yan	Journal of Cardiovascular Development and Disease	2018
PDE1A inhibition elicits cGMP-dependent relaxation of rat mesenteric arteries: PDE1A inhibition mediates cGMP-induced relaxation MM Khammy, T Dalsgaard, PH Larsen, CT Christoffersen, D Clausen, LK Rasmussen, L Folkersen, M Grunnet, J Kehler, C Aalkjaer, J Nielsen	British Journal of Pharmacology	2017
Mechanisms of Vascular Defects in Diabetes Mellitus CC Kartha, S Ramachandran, RM Pillai	Mechanisms of Vascular Defects in Diabetes Mellitus	2017
Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective P Bobin, M Belacel-Ouari, I Bedioune, L Zhang, J Leroy, V Leblais, R Fischmeister, G Vandecasteele	Archives of Cardiovascular Diseases	2016
Cyclic nucleotide phosphodiesterase-1C ( PDE1C ) drives cell proliferation, migration and invasion in glioblastoma multiforme cells in vitro: CYCLIC NUCLEOTIDE PHOSPHODIESTERASE-1C (PDE1C) FB Rowther, W Wei, TP Dawson, K Ashton, A Singh, MP Madiesse-Timchou, DG Thomas, JL Darling, T Warr	Molecular Carcinogenesis	2015
Cyclic nucleotide phosphodiesterase 1 and vascular aging C Yan	Clinical Science	2015
Role of cAMP-Phosphodiesterase 1C Signaling in Regulating Growth Factor Receptor Stability, Vascular Smooth Muscle Cell Growth, Migration, and Neointimal HyperplasiaNovelty and Significance Y Cai, DJ Nagel, Q Zhou, KD Cygnar, H Zhao, F Li, X Pi, PA Knight, C Yan	Circulation research	2015
Cyclic nucleotide-based therapeutics for chronic obstructive pulmonary disease MA Giembycz, DH Maurice	Current Opinion in Pharmacology	2014
Methods in Molecular Biology KF Held, WR Dostmann	Methods in molecular biology (Clifton, N.J.)	2013
β-Adrenergic cAMP signals are predominantly regulated by phosphodiesterase type 4 in cultured adult rat aortic smooth muscle cells K Zhai, F Hubert, V Nicolas, G Ji, R Fischmeister, V Leblais	PloS one	2012
Sub-Nanomolar Sensitivity of Nitric Oxide Mediated Regulation of cGMP and Vasomotor Reactivity in Vascular Smooth Muscle KF Held, WR Dostmann	Frontiers in pharmacology	2012
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterases as Drug Targets SH Francis, M Conti, MD Houslay		2011
Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling X Tian, C Vroom, HA Ghofrani, N Weissmann, E Bieniek, F Grimminger, W Seeger, RT Schermuly, SS Pullamsetti	PloS one	2011
PDE1 isozymes, key regulators of pathological vascular remodeling S Chan, C Yan	Current Opinion in Pharmacology	2011
Current Topics in Developmental Biology JE Qualls, PJ Murray	Cancer and Development	2011
Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling X Tian, C Vroom, HA Ghofrani, N Weissmann, E Bieniek, F Grimminger, W Seeger, RT Schermuly, SS Pullamsetti, W El-Rifai	PloS one	2011
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions SH Francis, MA Blount, JD Corbin	Physiological reviews	2011
Decreased cGMP Level Contributes to Increased Contraction in Arteries From Hypertensive Rats: Role of Phosphodiesterase 1 FR Giachini, VV Lima, FS Carneiro, RC Tostes, RC Webb	Hypertension	2011
Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cells KI Jeon, H Jono, CL Miller, Y Cai, S Lim, X Liu, P Gao, JI Abe, JD Li, C Yan	The FEBS journal	2010
xPharm: The Comprehensive Pharmacology Reference A Vinh	xPharm: The Comprehensive Pharmacology Reference	2010
Textbook of Pulmonary Vascular Disease , JG Garcia, JB West, CA Hales, S Rich, SL Archer		2010
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
cGMP: Generators, Effectors and Therapeutic Implications HH Schmidt, F Hofmann, JP Stasch	Handbook of experimental pharmacology	2009
Therapeutic targets in pulmonary arterial hypertension CJ Rhodes, A Davidson, JS Gibbs, J Wharton, MR Wilkins	Pharmacology & Therapeutics	2009
The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-dependent protein kinase (PKG) vasorelaxant in human vascular tissue RL Gonçalves, C Lugnier, T Keravis, MJ Lopes, FA Fantini, M Schmitt, SF Cortes, VS Lemos	European Journal of Pharmacology	2009
Effects of KF19514, a Phosphodiesterase 4 and 1 Inhibitor, on Bronchial Inflammation and Remodeling in a Murine Model of Chronic Asthma T Kita, M Fujimura, S Myou, K Watanabe, Y Waseda, S Nakao	Allergology International	2009
Expression, activity, and function of phosphodiesterases in the mature and immature ductus arteriosus H Liu, V Manganiello, N Waleh, RI Clyman	Pediatric Research	2008
ABCD of the phosphodiesterase family: interaction and differential activity in COPD DM Halpin	International journal of chronic obstructive pulmonary disease	2008
Fosinopril Prevents the Pulmonary Arterial Remodeling in Sinoaortic-denervated Rats by Regulating Phosphodiesterase X Tao, YJ Zhang, FM Shen, YF Guan, DF Su	Journal of Cardiovascular Pharmacology	2008
PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries AJ Santos-Silva, E Cairrão, M Morgado, E Álvarez, I Verde	European Journal of Pharmacology	2008
Rosiglitazone Inhibits Acyl-CoA Synthetase Activity and Fatty Acid Partitioning to Diacylglycerol and Triacylglycerol via a Peroxisome Proliferator-Activated Receptor- -Independent Mechanism in Human Arterial Smooth Muscle Cells and Macrophages B Askari, JE Kanter, AM Sherrid, DL Golej, AT Bender, J Liu, WA Hsueh, JA Beavo, RA Coleman, KE Bornfeldt		2007
Differential display fingerprints: new approach to characterize smooth muscle cells and human coronary atherectomy tissues N Blaes, M Elbaz, F Heitz, E Caussé, Y Glock, J Puel, F Bayard	Pathologie Biologie	2007
Comprehensive Medicinal Chemistry II E Littler, XX Zhou	Comprehensive Medicinal Chemistry II	2007
Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1 F Murray, HH Patel, RY Suda, S Zhang, PA Thistlethwaite, JX Yuan, PA Insel	American journal of physiology. Lung cellular and molecular physiology	2007
Subcellular localization and regulation of type-1C and type-5 phosphodiesterases S Dolci, A Belmonte, R Santone, M Giorgi, M Pellegrini, E Carosa, E Piccione, A Lenzi, EA Jannini	Biochemical and Biophysical Research Communications	2006
Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary artery smooth muscle cells CV Garat, D Fankell, PF Erickson, JE Reusch, NN Bauer, IF McMurtry, DJ Klemm	Molecular and cellular biology	2006
Cyclic Nucleotide Phosphodiesterases in Health and Disease E Aandahl, O Witczak, K Tasken	Cyclic Nucleotide Phosphodiesterases in Health and Disease	2006
Cyclic Nucleotide Phosphodiesterases in Health and Disease: Role in Controlling Vascular Cyclic Nucleotide Signaling D Tilley, D Maurice	Cyclic Nucleotide Phosphodiesterases in Health and Disease: Role in Controlling Vascular Cyclic Nucleotide Signaling	2006
Cyclic Nucleotide Phosphodiesterases in Health and Disease: Nonselective Phosphodiesterase Inhibitors for Chronic Inflammatory Diseases M Giembycz	Cyclic Nucleotide Phosphodiesterases in Health and Disease: Nonselective Phosphodiesterase Inhibitors for Chronic Inflammatory Diseases	2006
Role of Nuclear Ca 2+ /Calmodulin-Stimulated Phosphodiesterase 1A in Vascular Smooth Muscle Cell Growth and Survival DJ Nagel, T Aizawa, KI Jeon, W Liu, A Mohan, H Wei, JM Miano, VA Florio, P Gao, VA Korshunov, BC Berk, C Yan	Circulation research	2006
Cardiovascular system as a ‘core’ of sexual life AI El-Sakka	Expert Opinion on Pharmacotherapy	2005
Phosphodiesterase 5 and effects of sildenafil on cerebral arteries of man and guinea pig C Kruuse, TS Khurana, SD Rybalkin, S Birk, U Engel, L Edvinsson, J Olesen	European Journal of Pharmacology	2005
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors RT Schermuly, C Inholte, AH Ghofrani, H Gall, N Weissmann, A Weidenbach, W Seeger, F Grimminger	Respiratory Research	2005
Cardiovascular implications in the use of PDE5 inhibitor therapy DH Maurice	International Journal of Impotence Research	2004
Cyclic Nucleotide Phosphodiesterase Activity, Expression, and Targeting in Cells of the Cardiovascular System DH Maurice, D Palmer, DG Tilley, HA Dunkerley, SJ Netherton, DR Raymond, HS Elbatarny, SL Jimmo	Molecular pharmacology	2003
Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells. Renard CB, Askari B, Suzuki LA, Kramer F, Bornfeldt KE	Diabetologia	2003
PDE5 is converted to an activated state upon cGMP binding to the GAF A domain SD Rybalkin, IG Rybalkina, M Shimizu-Albergine, XB Tang, JA Beavo	The EMBO Journal	2003
Norepinephrine induces slow calcium signalling in murine brown preadipocytes through the β-adrenoceptor/cAMP/protein kinase A pathway LP Dolgacheva, BB Abzhalelov, SJ Zhang, VP Zinchenko, GE Bronnikov	Cellular Signalling	2003
Handbook of Cell Signaling MF White	Handbook of Cell Signaling	2003
Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation Masami Shimizu-Albergine, Sergei D Rybalkin, Irina G Rybalkina, Robert Feil, Wiebke Wolfsgruber, Franz Hofmann, Joseph A Beavo	The Journal of neuroscience : the official journal of the Society for Neuroscience	2003
Individual Cerebellar Purkinje Cells Express Different cGMP Phosphodiesterases (PDEs): In Vivo Phosphorylation of cGMP-Specific PDE (PDE5) as an Indicator of cGMP-dependent protein kinase (PKG) Activation Shimizu-Albergine M, Rybalkin SD, Rybalkina IG, Feil R, Wolfsgruber W, Hofmann F, Beavo JA	Journal of Neuroscience	2003
Cyclic Nucleotide Phosphodiesterase 1C Promotes Human Arterial Smooth Muscle Cell Proliferation SD Rybalkin, I Rybalkina, JA Beavo, KE Bornfeldt	Circulation research	2002
Reduced Phosphodiesterase 3 Activity and Phosphodiesterase 3A Level in Synthetic Vascular Smooth Muscle Cells: Implications for Use of Phosphodiesterase 3 Inhibitors in Cardiovascular Tissues HA Dunkerley, DG Tilley, D Palmer, H Liu, SL Jimmo, DH Maurice	Molecular pharmacology	2002
The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation C Kruuse, SD Rybalkin, TS Khurana, I Jansen-Olesen, J Olesen, L Edvinsson	European Journal of Pharmacology	2001
Blunted peripheral vasodilatory response is a hallmark of progressive deterioration in mild to moderate congestive heart failure M Nakamura, N Arakawa, H Yoshida, S Saitoh, H Kon, K Hiramori	Journal of Cardiac Failure	2001
Human Ca2+/calmodulin-dependent phosphodiesterase PDE1A: novel splice variants, their specific expression, genomic organization, and chromosomal localization H Michibata, N Yanaka, Y Kanoh, K Okumura, K Omori	Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression	2001
Regulation of cGMP-specific Phosphodiesterase (PDE5) Phosphorylation in Smooth Muscle Cells SD Rybalkin, IG Rybalkina, R Feil, F Hofmann, JA Beavo	The Journal of biological chemistry	2001
Upregulation of Phosphodiesterase 1A1 Expression Is Associated With the Development of Nitrate Tolerance D Kim, SD Rybalkin, X Pi, Y Wang, C Zhang, T Munzel, JA Beavo, BC Berk, C Yan	Circulation	2001
Platelets JN George	The Lancet	2000
Molecular pathways of cyclic nucleotide-induced inhibition of arterial smooth muscle cell proliferation H Koyama, KE Bornfeldt, S Fukumoto, Y Nishizawa	Journal of Cellular Physiology	2000
Characterization and effects of methyl-2- (4-aminophenyl)-1,2-dihydro-1-oxo-7- (2-pyridinylmethoxy)-4-(3,4,5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (PDE5) J Kotera, K Fujishige, H Michibata, K Yuasa, A Kubo, Y Nakamura, K Omori	Biochemical Pharmacology	2000
Expression of Phosphodiesterase 4D ( PDE4D ) Is Regulated by Both the Cyclic AMP-dependent Protein Kinase and Mitogen-activated Protein Kinase Signaling Pathways: A POTENTIAL MECHANISM ALLOWING FOR THE COORDINATED REGULATION OF PDE4D ACTIVITY AND EXPRESSION IN CELLS H Liu, D Palmer, SL Jimmo, DG Tilley, HA Dunkerley, SC Pang, DH Maurice	The Journal of biological chemistry	2000
Dual Expression and Differential Regulation of Phosphodiesterase 3A and Phosphodiesterase 3B in Human Vascular Smooth Muscle: Implications for Phosphodiesterase 3 Inhibition in Human Cardiovascular Tissues D Palmer, DH Maurice	Molecular pharmacology	2000
Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney TP Dousa	Kidney International	1999
Pentoxifylline Inhibits Neointimal Formation and Stimulates Constrictive Vascular Remodeling After Arterial Injury PR Hansen, AM Holm, JH Qi, T Ledet, LM Rasmussen, CB Andersen	Journal of Cardiovascular Pharmacology	1999
Inhibition of calmodulin-stimulated (Ca2+ + Mg2+)-ATPase activity by dimethyl sulfoxide E Mcconnell, M Wagoner, C Keenan, B Raess	Biochemical Pharmacology	1999
Therapeutic Potential of Selective PDE Inhibitors in Asthma C Schudt, F Gantner, H Tenors, A Hatzelmann	Pulmonary Pharmacology & Therapeutics	1999
Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro RM Wallis, JD Corbin, SH Francis, P Ellis	The American Journal of Cardiology	1999
Crosstalk Between Protein Kinase A and Growth Factor Receptor Signaling Pathways in Arterial Smooth Muscle KE Bornfeldt, EG Krebs	Cellular Signalling	1999
Anti-Inflammatory Drugs in Asthma AP Sampson, MK Church		1999
Identification, Quantitation, and Cellular Localization of PDE1 Calmodulin-Stimulated Cyclic Nucleotide Phosphodiesterases WK Sonnenburg, SD Rybalkin, KE Bornfeldt, KS Kwak, IG Rybalkina, JA Beavo	Methods	1998
Calmodulin and Signal Transduction J Hu, LJ van Eldik	Calmodulin and Signal Transduction	1998
Different Proliferative Responses of G_i/o-Protein-Coupled Receptors in Human Myometrial Smooth Muscle Cells: A Possible Role of Calcium UK Nilsson, M Grenegçrd, G Berg, SP Svensson	Journal of Molecular Neuroscience	1998
Progress in Nucleic Acid Research and Molecular Biology FS Collins, SM Weissman	Progress in nucleic acid research and molecular biology	1984

Advertisement